Related by context. All words. (Click for frequent words.) 71 unvested stock 69 unvested options 68 unvested 67 vesting 66 unvested restricted stock 65 units RSUs 63 Long Term Incentive Plan 63 Equity Incentive Plan 61 Stock Incentive Plan 61 nonequity incentive plan 61 LTIP 59 deferred compensation 59 Restricted Share 59 compensation expense 59 vest ratably 59 unexercised stock 58 severance 58 RSUs 58 Restricted Stock 58 DSUs 58 vesting provisions 58 FAS #R 58 Incentive Compensation Plan 57 exercisability 57 unexercised options 56 shares issuable 56 Appreciation Rights 56 Accelerated vesting 56 SFAS #R 56 adopting SFAS #R 56 unexercisable options 56 SMTEK 56 Unvested 56 Statement #R 55 Incentive Plan 55 Inducement Award 55 Based Compensation 55 nonvested 55 Annual Incentive Plan 55 Omnibus Incentive Plan 54 No. #R 54 severance accruals 54 unamortized financing 54 dilutive securities 54 improperly backdated 53 misdated stock 53 compensation accruals 53 expensing 53 Long Term Incentive 53 Units RSUs 53 nonequity incentives 53 unvested restricted shares 53 - -Frode Johnsen 53 Employment Inducement Award 53 misdating 53 shares issuable upon 53 unvested deferred 52 postretirement benefit 52 incentive LTI 52 nonequity incentive 52 RSUs granted 52 earnout payments 52 unamortized deferred 52 shares issuable pursuant 52 involuntary termination 52 FDIC indemnification 52 No. #R SFAS 52 Stock Option 52 unexercised 52 unexercised warrants 51 unissued ordinary shares 51 debt extinguishments 51 Share Option 51 Pro forma adjustments 51 exercisable 51 issuable upon exercise 51 FASB #R 51 Deferred Compensation Plan 51 antidilutive 51 Employee Incentive Plan 51 convertible promissory notes 51 No. #R Share 51 FAS#R 51 severance payouts 51 profitsharing 51 nonrecurring expenses 51 Visa indemnification 51 Option Plan 50 repurchase authorizations 50 exerciseable 50 Dilutive effect 50 beneficially owned approximately 50 nonqualified deferred compensation 50 expired unexercised 50 deductible goodwill impairment 50 adopted SFAS #R 50 C Convertible Preferred 50 Neurogen stockholders 50 issuable 50 unvested restricted 50 improper backdating 50 B Preferred Stock 50 Long Term Incentive Compensation 50 ACLARA 50 SFAS#R 50 underwriting discounts commissions 50 unamortized debt 50 nonforfeitable 50 Incentive Stock 50 noncash goodwill impairment 50 FAS# R 50 nonemployee directors 50 B Convertible Preferred 50 ESPP 50 Ception 50 loss NOL carryforward 50 Contingent Value Rights 50 Noncash 50 unconsolidated investee 50 stock basedcompensation 50 accrual reversal 50 EBITDAS EBITDA 50 convertible redeemable preferred 50 noncash goodwill 50 intangible assets impairment 50 nondeductible expenses 49 Option Schemes 49 Stapled Units 49 Adjusted EBITDA excludes 49 unamortized issuance costs 49 earnout 49 restatement 49 Valeant stockholders 49 Compensation Expenses 49 Inducement Stock 49 Performance Incentive Plan 49 unamortized portion 49 dilutive effect 49 b Represents 49 underwriters overallotment option 49 incentive accruals 49 Dilutive 49 unamortized deferred financing 49 bonus accruals 49 pretax noncash 49 Compensation Expense 49 nonqualified 49 lump sum distributions 49 redeemable preferred stock 49 commonstock 49 repricings 49 Cortelco 49 misdated options 49 B Cumulative Preferred 49 Exercisable 49 exclude noncash 49 Evercore LP 49 pretax goodwill impairment 49 issuable pursuant 49 receive nonforfeitable dividends 49 share repurchase authorizations 49 Inducement Equity Incentive Plan 49 Dilutive securities 49 Compensation Warrants 49 SFAS #R Share 49 Directors Deferred Compensation 49 LIFO accounting 49 Underwriter Warrants 49 promissory notes payable 49 Symphony Icon 49 improperly backdating 49 contingently issuable shares 49 exchangeable debentures 49 -triseries 49 pension curtailment 48 senior subordinated convertible 48 Shares issuable pursuant 48 convertible subordinated notes 48 indemnification obligations 48 Employee Stock 48 b Reflects 48 contingently convertible debt 48 accrual reversals 48 Unearned compensation restricted 48 severance package 48 Finders Warrants 48 APB# 48 -Winchester Thurston 48 fraudulently backdated 48 Innovis Entities 48 Based Compensation Expense 48 Convertible Debt 48 Unizan merger 48 Harland Acquisition 48 EPE unitholders 48 non forfeitable dividends 48 Excluding goodwill impairment 48 unamortized 48 Xphase 48 golden parachute 48 postretirement 48 Qualcomm Strategic Initiatives 48 Non Brokered Offering 48 expire unexercised 48 d Represents 48 c Includes 48 GSCT program 48 Accelerated Share Repurchase 48 LM Capital Markets 48 Contingent Value Right 48 stockholder approval 48 EP MedSystems shareholders 48 noncash 48 LIFO inventory valuation 47 Employment Inducement Equity Incentive 47 Endo Pharma LLC 47 addback 47 underwriters overallotment 47 Xphase principals 47 X Ceptor 47 Financing Transactions 47 OCEANE bonds 47 LIFO adjustments 47 underwriter overallotment option 47 c Represents 47 f Represents 47 Long Term Incentive Program 47 VaxGen stockholders 47 adopting FAS #R 47 TSARs 47 convertible notes 47 Share repurchases 47 intangible asset impairments 47 Stock Options 47 RSU Plan 47 -MarketPlace# TM 47 unearned ESOP 47 Inducement Grant 47 Argosy Warrants 47 disinterested shareholder 47 vesting ratably 47 ratably 47 Backdating involves manipulating 47 noninterest expense decreased 47 Plan ESPP 47 Stock Ownership 47 NASDAQ Marketplace Rule 47 scheme ESOS 47 DAC unlock 47 ESOP Scheme 47 dacetuzumab collaboration 47 disqualifying dispositions 47 convertible subordinated 47 variable remuneration 47 Shares issuable upon 47 RSUs vest 47 FSAH acquisition 47 unallocated ESOP shares 47 Secured Convertible Notes 47 mandatorily redeemable 47 Option Scheme 47 MDS Proteomics 47 % Convertible Subordinated 47 repurchases 47 Copano commodity 47 CDR Private Placement 47 convertible subordinated debentures 47 OTTI charges 47 option expensing 47 asset impairments severance 47 mandatorily redeemable preferred 47 Antler Creek Shares 47 Contingent Consideration 47 Merger Transaction 46 FASB Statement #R 46 reinsurance commutations 46 expensed 46 discount accretion 46 postretirement benefit expense 46 SFAS No.#R 46 convertible exchangeable 46 nonvested shares 46 debt extinguishment 46 Cumulative Convertible Perpetual Preferred 46 GHL Acquisition 46 elective deferrals 46 perquisites 46 repurchase ASR 46 Surface Specialties acquisition 46 commodity derivative instruments 46 Assumed exercise 46 convertible debentures 46 backdating 46 earnouts 46 finder fee payable 46 FSAH Acquisition 46 Miikana Therapeutics 46 redomestication 46 quarterended 46 dis synergies 46 unallocated expenses 46 Accrued severance 46 contingently issuable 46 Optionholder 46 Montaur 46 On2 stockholders 46 golden parachute arrangements 46 earnout provision 46 Redeemable Preferred 46 Symphony GenIsis 46 Proposed Transactions 46 Stapled Unit 46 excludes noncash 46 Nortek Holdings 46 severance packages 46 STOCK BASED COMPENSATION 46 Finders Option 46 per dilutedshare 46 noncurrent liabilities 46 Bonus Warrants 46 MFB Corp 46 Share Repurchase Plan 46 reissuances 46 mandatorily convertible preferred 46 noncontract employees 46 Lodging Reported EBITDA 46 Including discontinued operations 45 consents authorizations 45 Stapled Unit options 45 beneficially owning 45 Related Parties 45 convertible debenture 45 remaining untendered 45 DJO Merger 45 severance outplacement 45 QUALCOMM Strategic Initiatives 45 Combination Agreement 45 unsecured subordinated debentures 45 redeemable convertible preferred 45 Expired warrants 45 Overallotment Option 45 indebtedness incurred 45 Senior Convertible Notes 45 Greenshoe option 45 SFAS No. 45 Finder Warrants 45 Cumulative Convertible 45 Acquired Intangible Assets 45 amortization expense 45 golden parachute payments 45 Underwriters Over Allotment 45 pershare 45 Huarun minority interest 45 Inducement Plan 45 OTTI charge 45 FT Units subscribed 45 Vesting 45 Repurchase Program 45 deducting underwriting commissions 45 Convertible Subordinated Debt 45 = Earnings [007] 45 secured convertible debentures 45 Reporting Person 45 - Weighted average [004] 45 misdated 45 Vesting Date 45 Ptek 45 overallotment provision 45 = Weighted average [003] 45 warrants exercisable 45 Value Creation Plan 45 buyback authorization 45 - -Neko Entertainment 45 Chubb repurchased 45 foreign currency remeasurement 45 Canaccord Relief Program 45 dividends thereon 45 Arana Therapeutics Limited 45 Inducement Awards 45 #R Share Based 45 PGP Acquisition 45 = Basic earnings [010] 45 AutoZone repurchased 45 contingent earnout 45 Normalized EPS 45 inventories revalued 45 Weighted Weighted Average 45 - Balance [002] 45 early extinguishment 45 Metallic Ventures 45 Xantic 45 Secured Debenture 45 Expensing 45 QSI segment certain 45 Inc. NASDAQ EVVV 45 Senior Secured Convertible Debentures 45 USPoly 45 - -Belusko 45 OTTI write downs 45 Purchase Warrants 45 Triggering Event 45 Vishay stockholders 45 fraudulently backdate 45 Board ofDirectors 45 convertible promissory note 45 Noninterest expenses 45 Cwirko Godycki 45 Inc. OTC CDCO 45 ESPPs 45 c Reflects 45 NYSE Rule #A.# 45 NETg acquisition 45 finder warrants exercisable 44 GMIB 44 Subordinate Voting Stock 44 optionee 44 NOL carryforwards 44 -DAVID BRUCE 44 DiaMed acquisition 44 lump sum payments 44 aftertax charge 44 noncumulative perpetual preferred 44 ESOS 44 Noninterest expense decreased 44 Brokered Placement 44 Susquehanna NASDAQ SUSQ 44 OPEB expense 44 improperly backdated stock 44 secured promissory note 44 Including unvested 44 #.# perdiluted 44 antidilution 44 Convertible Preferred Shares 44 SumTotal stockholders 44 Backdating involves issuing 44 NOL utilization 44 AVONEX multiple sclerosis 44 Existing Debentures 44 Nonqualified 44 Relevant Period 44 millioncompared 44 Reimbursement Agreement 44 underwriters exercised 44 intangible impairment 44 dilutive 44 LIFO adjustment 44 Early Settlement Date 44 Symphony ViDA 44 earnings pershare 44 Restated Certificate 44 Inc. NASDAQ THRX 44 ZBx 44 contingently convertible 44 Business.com Acquisition 44 subsidiary Limco Piedmont 44 Convertible Notes 44 unissued shares 44 Stockholder Rights Plan 44 b Excludes 44 Earnout 44 Interest expense decreased 44 EITF #-# [001] 44 unrealized appreciation 44 FAS #R Accounting 44 Repurchased 44 nondividend distribution 44 Filtran Microcircuits Inc. 44 ESOP Employee 44 - -Deccan Mujahideen 44 Rule #a 8 44 Gamecorp 44 Shares issuable 44 VERISIGN INC. AND SUBSIDIARIES 44 Adjusted diluted 44 buyback authorizations 44 Contributed surplus 44 MA PFFS 44 Senior Secured Convertible Notes 44 Non GAAP adjusted EBITDA 44 option repricings 44 Inc. Nasdaq PVTB 44 -Sam Sparro 44 accretion expense 44 Amended Option Agreement 44 #,#,# warrants exercisable 44 lump sum payouts 44 Cambium Voyager Holdings 44 graded vesting 44 Share Incentive Plan 44 excludes depreciation amortization 44 Recapitalization Agreement 44 NOVT 44 contingently convertible securities 44 FASB Interpretation No. 44 CEO Steven Reinemund 44 indenture governing 44 renamed Pell Grants 44 depreciation amortization depletion 44 Subsidiary Guarantors 44 Inducement Warrants 44 Montigen Pharmaceuticals 44 Each Finder Warrant 44 Existing Warrants 44 Incentive Options 44 #.#/diluted share 44 clawback provision 44 ticker symbol CFN 44 ViewPoint MHC 44 Cumulative Convertible Redeemable Preferred 44 lease terminations 44 QSI segment 44 finders warrants 44 Proposed Financing 44 Upper DECS 44 non forfeitable 44 ReNvision 44 optionholder 44 Unexercised options 44 NeuroMedix 44 Inc. Nasdaq ZILA 44 compensation 44 promissory note payable 44 Long Term Equity Incentive 44 - -Justin Timberlake Boyz 44 Payment FAS #R 44 retention bonuses 44 Repurchases 44 NewMil 44 Repurchase 44 - -Anne Fadiman 44 backdating scandal 44 PlanVista 44 Warrants exercisable 44 Genader 44 NONINTEREST EXPENSES Salaries 43 Equity Inducement 43 Subordinated Note 43 PMPS brand 43 USED IN FINANCING ACTIVITIES 43 LPT Agreement 43 - Non Shane Germann 43 exchangeable notes 43 Executive VP Exercises 43 ANS Parties 43 compensa tion 43 Convertible Redeemable Preferred Stock 43 AOCL 43 Conexant stockholders 43 intercompany indebtedness 43 Cellu Tissue stockholders 43 CICA Handbook section 43 accrual 43 Edgen Corporation 43 nonoperating expense 43 DNOI 43 Cyries 43 TSX THI 43 Stock Repurchase Plan 43 #b# 1 43 InteliStaf 43 accelerated expiry 43 Concateno plc 43 HiMEDS Units 43 Compensation 43 non recurring 43 FSP EITF #-#-# [002] 43 Finder Warrant Share 43 repurchased 43 Redeemable convertible preferred 43 = Average [015] 43 mandatorily redeemable convertible 43 FAS #R Share 43 Adjusted OIBDA excludes 43 Metabasis stockholders 43 ADSs tendered 43 acquisitions divestitures joint ventures 43 Sr. VP Exercises 43 vested 43 Underwriters Option 43 Cashless exercise 43 Northquest 43 -Artunduaga 43 deducting underwriters 43 deducting underwriting 43 Unearned compensation 43 EnerCare Solutions 43 unabsorbed manufacturing 43 CVRs 43 Convertible Preferred 43 NYSE TSX BVF 43 nonoperating income 43 restatements 43 - Adjusted [022] 43 QTDP grants 43 asset valuation allowance 43 SFAS# R 43 Preferred Stock 43 Excluding nonrecurring items 43 Y Cumulative Preferred 43 Termination Benefits 43 unrealized depreciation 43 Convertible Preferred Stock 43 Fixed Rate Cumulative Preferred 43 Domestic Car Rental 43 Fully diluted weighted 43 termination 43 intangible impairments 43 Finders fees 43 Finder Option 43 currency remeasurement 43 share repurchase authorization 43 fully diluted 43 depreciation amortization accretion 43 retrospectively adjusted 43 LYONs 43 Acceptance Date 43 Amalco Shares 43 Convertible Perpetual Preferred Stock 43 netincome 43 accruals 43 Dividend Reinvestment 43 Avantome Inc. 43 fractional shares 43 Warrant Expiry Date 43 Pro forma diluted 43 Assumes conversion 43 NetApp Data Domain 43 CASM excluding fuel 43 your FIRST DEPOSIT 43 asset impairments restructuring 43 liquidating distributions 43 Unlisted Options 43 Deferred Compensation 43 LTIPs 43 RidgewaterEquity.com 43 uncollectible accounts receivable 43 Convertible Debentures 43 TRCLP Notes 43 carryforwards 43 Roger Enrico 43 Issuer Amended 43 Commencement Date 43 - Adjusted EBITDA [006] 43 imputed dividend 43 COLI policies 43 repurchase 43 Maple Merger Sub 43 CSRS Offset 43 Amnon Landan 43 MEP Joint Venture 43 Financing Activities Issuance 43 backdated 43 Rule #b# 1 43 -Benton Harbor MI 43 Forgeard exercised 43 Invitel Denmark 43 Deregister Its Common 43 derivative liabilities 43 c Relates 43 Projected FFO 43 broker warrants exercisable 43 Debt Settlement Agreements 43 Broker Warrants 43 Xantic acquisition 43 Interpublic Declares Dividend 43 optionees 43 retroactively restated 43 repricing 43 Long Term Retention 43 Brokered Offering 43 Cumulative Perpetual Preferred Stock 43 Subsequent Offering 43 Subordinate Note 43 aftertax gain 43 Outstanding Options Exercisable 43 applied prospectively 43 Accelrys Symyx 43 Chesstown 43 Restated 43 Senior Exchangeable Preferred 43 FRANKFURT JE9 OTCBB DARUF 43 Leland Brendsel 43 Debenture 43 Zero Coupon Convertible Notes 42 GMDB 42 Encore Bancshares 42 Common Share Purchase 42 Noneconomic damages 42 Plan ESOP 42 Endocare stockholders 42 Perpetual Preferred Stock 42 perquisite allowance 42 Waymar 42 Denominator Weighted average 42 NON INTEREST EXPENSES Salaries 42 involuntarily terminated 42 intersegment revenues 42 optionholders 42 Biomerge 42 BCGold Corp. BCGold 42 Perlite Canada inc 42 Adjusted EBTIDA 42 Adjustments Restructuring 42 #,#,# Unlisted Options 42 Unearned restricted 42 ended December# 42 Proginet stockholders 42 voluntary prepayment 42 DAC unlocking 42 AGY Asia 42 revolver borrowings 42 Zero Coupon Convertible Subordinated 42 f Reflects 42 Senior Toggle Notes 42 intangibles amortization 42 Conditional Asset 42 Over Allotment 42 Apex Bioventures 42 Mandatory Convertible Preferred Stock 42 ANYT Common Stock 42 Options exercisable 42 Acquisition Transaction 42 goodwill impairments 42 #.#per diluted 42 unreduced pension 42 Toggle Notes 42 early extinguishments 42 Flow Through Offering 42 adopting SFAS 42 Position APB #-# 42 Skyberry 42 Unconsolidated Investments 42 Mr. Perlegos 42 Hesperion acquisition 42 Drosdick 42 CONSTA secured 42 - Non GAAP [021] 42 Compensation Option 42 nonemployee 42 NitroMed stockholders 42 Contingent consideration 42 Successor Period 42 Nasdaq MAXM SSE MAXM 42 Consolidated OIBDA 42 Non Controlling Interests 42 Realized gains 42 oversubscription privilege 42 DPAC amortization 42 Adjusted FIFO EBITDA 42 Variable Interest Entities VIEs 42 j Represents 42 OFCD Optionally Fully 42 Purchase Warrant 42 CompAir acquisition 42 Citadel SMaRT 42 #,#,# ADSs [001] 42 ceding commissions 42 Convertible Subordinated Notes 42 earnout payment 42 Proforma EBITDA 42 convertible debenture financing 42 Sharlene Abrams 42 unamortized discount 42 Dagilev 42 TSX VENTURE XCT 42 Convertible Senior Subordinated 42 Interest Expense Interest expense 42 Concurrent Financing 42 unused vacation 42 Photop 42 Inrange Technologies 42 Non GAAP Diluted EPS 42 salaried retiree 42 Variable Remuneration 42 purchase warrants exercisable 42 Reports Inducement Grants 42 nonvested stock 42 Refinancing Transactions 42 - -OSCAR WINNING 42 symbol LRI 42 Visa MasterCard antitrust 42 Agent Warrant 42 Conversion Period 42 -Emma Jennifer Schwalbach 42 accreted principal 42 Scheme Consideration 42 depreciation depletion amortization 42 Units issuable 42 Subordinated Convertible Notes 42 Senior Subordinated Convertible Notes 42 FAS CAS pension 42 NASDAQ EPMD 42 ALICO Holdings 42 Ideation Acquisition Corp. 42 accretable 42 OREO valuation 42 PharmaBio 42 acquired intangible assets 42 share repurchases 42 Diluted EPS attributable 42 dilution 42 AOCI 42 dilutive issuances 42 Merger Agreement 42 Unsecured Debentures 42 principal paydowns 42 BacTech Environmental 42 thetransaction 42 FHLMC preferred stock 42 AJCA 42 d Reflects 42 Backdating involves 42 Aon Benfield restructuring 42 Redeemable Preferred Stock 42 Geomark 42 Mr. Mordechay Zisser 42 Common Share Common Share 42 CapGen Offering 42 subordinated promissory note 42 exchangeable shares 42 Subordinated convertible debentures 42 BridgewaterEquity.com 42 Partnered Brands segment 42 Therics 42 beneficially owned 42 collectively beneficially 42 repurchase authorization 42 Fixed remuneration 42 Underwriters Exercise 42 Diluted FFO 42 unabsorbed fixed overhead 42 -Mr Micawber 42 unrealized derivative gains 42 subordinated indebtedness 42 mildly dilutive 42 Optionees 42 Indentures governing 42 Rule #b 42 = Weighted averageFloodwaters receded 42 ZelnickMedia 42 affecting comparability 42 #,# -oxidative enzymes 42 ceded reinsurance 42 pro rata portion 42 Jean Madar owns 42 EdgeStone Funds 42 Technest 42 severances 42 Warrant Exercise 42 InfoSpherix subsidiary 42 Janssen AI 42 Cortelco Shanghai 42 CellStar Corporation 42 Conversion Price 42 Company noncontributory defined 42 Illumigen 42 Compensation Options 42 Restructured Canwest 42 Petrofund merger 42 MDP Transaction 42 non recourse RISPERDAL 42 noncash accounting 42 #,#,# Contributed surplus 42 equal installments 42 Semcan 42 - BaImprint Newspapers 42 - -inculpatory 42 = Basic [035] 42 postemployment 42 Minimum Condition 42 Senior Secured Debentures 42 Postemployment 42 unrealized derivative losses 42 Secured Convertible Debentures 42 identifiable intangibles 42 Curtailment gain 42 modestly dilutive 42 Pro forma EPS 42 accretable yield 42 Primedex 42 CEO Leland Brendsel 42 TEB adjustment 42 nonconvertible preferred 42 CalFirst Bancorp 42 fuel CASM 42 unrealized derivative 42 Appendix 3B Exercise 42 Variable remuneration 42 unamortised 42 BostonFed 42 goodwill impairment charge 42 Disinterested shareholders 41 reincorporation merger 41 Nasdaq ETWC 41 prepetition liabilities 41 - Non GAAP [015] 41 sheltered annuity 41 obj obj = 41 American Jobs Creation 41 Black Scholes Merton 41 unfavorable variance 41 unabsorbed fixed manufacturing 41 continuingoperations 41 Medigen 41 nonroutine income 41 PDMR 41 re pricings 41 NASDAQ CYBS 41 - AdjusETON 41 INOVA Geophysical 41 c Consists 41 minimally dilutive 41 warrantholder 41 Positively impacting 41 Unearned Employee 41 QT Financing 41 loss carryforward 41 temporary impairment OTTI 41 Tolmar 41 postretirement expense 41 Preferred Units 41 dilutive antidilutive effects 41 Mircette R 41 NONINTEREST EXPENSE Salaries 41 CEFF 41 Pharmagesic 41 FSP APB #-# 41 Vyvx advertising 41 compen sation 41 Icefloe 41 proxy statement 41 ReAble 41 noninterest expense partially offset 41 toreflect 41 SFAS 41 NASDAQ PZZ 41 unrealized derivative gain 41 reinsurance commutation 41 Non GAAP Adjusted 41 perpetual preferred 41 Final Settlement Date 41 -APRIL #TH DAY 41 Brooks Eckerd acquisition 41 Barrett NDEx 41 fraudulently backdated stock 41 ESOP 41 NASDAQ Listing Rule 41 ELIOKEM 41 = Weighted average [024] 41 Polymer Additives segment 41 - Adjusted [024] 41 FSAH 41 - - Weighted average 41 Excess Cash Flow 41 marketable securities totaled 41 warrant Warrant exercisable 41 convertible perpetual 41 Subordinated Noteholders 41 Novogyne 41 MCTO 41 TSX VENTURE STT 41 RTO Financing 41 Fully diluted earnings 41 Perseid Therapeutics LLC 41 eXegenics 41 YTD Period 41 reorganized Delphi 41 EURO#.# [002] 41 Debt Extinguishment 41 unfunded accrued 41 CRIC shareholders 41 Other Expenses Salaries 41 = Net [017] 41 - Adjusted [031] 41 aftertax 41 noncash pretax charge 41 indemnifications 41 - Stockholders Equity [006] 41 D Cumulative Redeemable 41 CSBU 41 purchased intangible assets 41 Glatfelter Declares Dividend 41 Privateco 41 outplacement assistance 41 junior subordinated debentures 41 NASDAQ CCBI 41 Senior Secured Convertible 41 Repurchased shares 41 ClickFind 41 tendered pursuant 41 Non FT Units 41 SEMCAN 41 restate financials 41 NYSE CXS 41 EMEA Subsidiaries 41 temporary impairments 41 excluding BIBP 41 TSX VENTURE VRW 41 accrued